A detailed history of Pathstone Family Office, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 20,500 shares of BHC stock, worth $151,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,500
Holding current value
$151,495
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$7.69 - $9.71 $157,645 - $199,055
20,500 New
20,500 $168,000
Q1 2021

May 14, 2021

SELL
$21.37 - $34.38 $10,685 - $17,190
-500 Closed
0 $0
Q1 2020

Jun 11, 2020

BUY
$12.98 - $30.25 $6,490 - $15,125
500 New
500 $8,000
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $9,445 - $15,945
-500 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$20.23 - $26.29 $10,115 - $13,145
500 New
500 $12,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.